US 7,413,570 B2Grant

Medical closure screen installation systems and methods

Issue Date:2008-08-19

•8 Claims

•46 Drawing Sheets

Abstract

A medical closure screen device for a separation of first and second tissue portions is provided, which includes a mesh screen comprising tubular vertical risers, vertical strands with barbed filaments, and horizontal spacers connecting the risers and strands in a grid-like configuration. An optional perimeter member partly surrounds the screen and can comprise a perimeter tube fluidically coupled with the vertical risers to form a tubing assembly. Various input/output devices can optionally be connected to the perimeter tube ends for irrigating and/or draining the separation according to methodologies of the present invention. Separation closure, irrigation and drainage methodologies are disclosed utilizing various combinations of closure screens, tubing, sutures, fluid transfer elements and gradient force sources. The use of mechanical forces associated with barbed strands for repositionably securing separated tissues together is disclosed. The use of same for eliminating or reducing the formation of subcutaneous voids or pockets, which can potentially form hematoma and seroma effects, is also disclosed. Further disclosed are alternative embodiment medical closure screen installation systems and methods.

Metadata

Assignee

KCI Licensing, Inc.

Inventor

David S. Zamierowski

Application Information

Application Number:US 11/103,022

Filing Date:2005-04-11

Priority Date:2002-08-21

Art Unit:3734

Classifications

IPC:

A61B17/08

Patent Drawings (46 sheets)

Description

Cross-Reference to Related Application

[0001] This application is a continuation-in-part of U.S. patent application Ser. No. 10/224,852 filed on Aug. 21, 2002 currently pending in the United States Patent Office, and is incorporated herein by reference.

Background of the Invention

[0002] 1. Field of the Invention

[0003] The present invention relates generally to medical closure and wound fluid management devices, and in particular to installation systems and methods for screen closure members and devices for closing tissue separations, such as incisions and wounds, which closure members and devices are optionally bioabsorbable.

[0004] 2. Description of the Prior Art

[0005] In the medical field, which is broadly defined to include dentistry, veterinary medicine, etc., cutaneous incisions are commonly performed in surgery to provide access to underlying tissue, organs, joints, skeletal structure, etc. Incision and closure techniques are an important part of surgery in general. They tend to occupy surgical teams and other resources for significant portions of many surgical procedures.

[0006] Surgeons generally strive to minimize the traumatic and scarring effects of surgery on their patients by both minimizing the incisions, and by employing a variety of closure techniques which tend to reduce postoperative swelling, bleeding, seroma, infection and other undesirable postoperative side effects. For example, the fields of endoscopic-assisted surgery, microscopic surgery, and computer-enhanced instrumentation (e.g., the DaVinci System available from Intuitive Surgical, Inc. of Sunnyvale, Calif.) are generally concerned with minimally invasive surgery (“MIS”) procedures and techniques, which have proven to be increasingly popular. Such popularity is at least partly due not only to the minimally-sized scars left by such techniques, but also to the minimal trauma to the fascia and muscle layers and the correspondingly faster recoveries this allows. However, surgeons must balance such considerations with providing adequate access to perform various surgical procedures. A typical surgical procedure involves a cutting or dissecting phase and a closing phase. In recent years, considerable progress has been made in minimizing surgical cutting, dissecting and shaping. Surgical closing techniques involve sutures, clips, staples and adhesives. However, suturing can be time-consuming and tedious. Moreover, the tissue structures to be joined may not be amenable to other closure techniques. MIS often restricts access to the separated tissue structures, thus making it more difficult to approximate and close same.

[0007] In contrast to MIS, some surgical procedures, by their nature, must include long incisions. Examples include cutaneous excisional procedures such as “lifts” and reduction procedures, flap procedures for closure of defects, and many bariatric procedures. Suturing in these extensive defects can be time-consuming and tedious.

[0008] The “first intention” (primary intention healing) in surgery is to “close” the incision. For load-bearing tissues, such as bone, fascia, and muscle, this requires substantial material, be it suture material, staples, or plates and screws. For the wound to be “closed,” the epithelial layer must seal. To accomplish this, the “load bearing” areas of the cutaneous and subcutaneous layers (i.e., the deep dermal elastic layer and the superficial fascia or fibrous layers of the adipose tissue, respectively) must also at least be held in approximation. Important considerations include controlling infection and bleeding, reducing scarring, eliminating the potential of hematoma, seroma, and “dead-space” formation and managing pain. Dead space problems are more apt to occur in the subcutaneous closure. Relatively shallow incisions can normally be closed with surface-applied closure techniques, such as sutures, staples, glues, and adhesive tape strips. However, deeper incisions may well require not only skin surface closure, but also time-consuming placement of multiple layers of sutures in the load-bearing planes. Absorbable sutures are commonly used for this purpose and comprise an important class of surgical sutures. Depending on various factors, absorbable sutures typically dissolve over a period of a few days to a few months. Commercially available examples include Monocryl® monofilament absorbable synthetic sutures comprising a poliglecaprone and PDS® (polydrioxanone) and Vicryl® (polyglactin) sutures, all available from Ethicon, Inc., of Somerville, N.J.

[0009] Surgical mesh is commonly used to span or reinforce load-bearing planes or defects in them. When coupled with sutures or fasteners, surgical mesh represents another important class of surgical closure devices. Applications include reconstruction, hernia repair, and organ repair. In such procedures, surgical mesh fabric prostheses are inserted into patients through either open surgery or endoscopic (MIS) procedures. Knitted surgical mesh for hernia repair is disclosed in the Agarwal et al. U.S. Pat. No. 6,287,316, which is assigned to Ethicon, Inc. Another Ethicon, Inc. patent, Duncan U.S. Pat. No. 4,548,202, discloses mesh tissue fasteners including various fastening members with spaced-apart legs for passing through tissue portions. Another closure procedure involves the placement of pins or rods through skin edge or bone followed by the placement of an external clamp or fixator device spanning the wound and frequently incorporating a worm-screw apparatus capable of progressive tightening over time to effect closure, stabilization or distraction.

[0010] Fluid management represents another important aspect of both open and minimally invasive surgery. Postoperative fluid drainage can be accomplished with various combinations of tubes, sponges, and porous materials adapted for gathering and draining bodily fluids. The prior art includes technologies and methodologies for assisting drainage. For example, the Zamierowski U.S. Pat. No. 4,969,880; U.S. Pat. No. 5,100,396; U.S. Pat. No. 5,261,893; U.S. Pat. No. 5,527,293; and U.S. Pat. No. 6,071,267 disclose the use of pressure gradients, i.e., vacuum and positive pressure, to assist with fluid drainage from wounds, including surgical incision sites. Such pressure gradients can be established by applying porous foam material either internally or externally to a wound, covering same with a permeable, semi-permeable, or impervious membrane, and connecting a suction vacuum source thereto. Fluid drawn from the patient is collected for disposal. Such fluid control methodologies have been shown to achieve significant improvements in patient healing. Another aspect of fluid management, postoperative and otherwise, relates to the application of fluids to wound sites for purposes of irrigation, infection control, pain control, growth factor application, etc. Wound drainage devices are also used to achieve fixation and immobility of the tissues, thus aiding healing and closure. This can be accomplished by both internal closed wound drainage and external vacuum devices. Fixation of tissues in apposition can also be achieved by bolus tie-over dressings (Stent dressings), taping, strapping and (contact) casting.

[0011] Heretofore, there has not been available a medical closure screen assembly with the advantages and features of the present invention, including the combination of same with negative pressure wound therapy (“NPWT”).

Summary of the Invention

[0012] In the practice of one aspect of the present invention, a medical closure screen device is provided, which includes a mesh screen comprising tubular vertical risers, barbed filaments therebetween and horizontal spacers. Integral or separate sutures can be provided. An optional perimeter member partly surrounds the screen member and can comprise a perimeter tube fluidically coupled with the vertical risers to form a tubing assembly. The tubing assembly cooperates with the vertical risers to extract fluid from the tissue separation in a drain mode and to introduce fluid thereinto in an irrigate mode. In one embodiment of the invention the tubing assembly is fluidically coupled to a vacuum source to facilitate drainage. In another embodiment of the invention, the perimeter tube is passed through the surrounding tissue to secure the screen member in place. Fluid transfer elements, such as sponges, are optionally placed adjacent to and over an extension of the screen for fluid transfer, for example, in conjunction with a vacuum or pump source. Another embodiment of the invention includes a suture connected to the screen and adapted for securing same in a tissue separation. Alternative embodiment vertical risers are also disclosed, and can provide active fluid transfer utilizing the patient's body dynamics. Yet another alternative embodiment of the present invention utilizes the screen barbs for mechanical fixation in a separation for closure of same. Separation closure, irrigation and drainage methodologies are disclosed utilizing various combinations of closure screens, tubing, sutures, fluid transfer elements and gradient force sources. The closure screen of the present invention uses mechanical and other forces associated with screens and barbed strands for securing separated tissues together and for eliminating or reducing the formation of subcutaneous voids or pockets, which can potentially form hematoma and seroma effects.

Brief Description of the Drawings

[0013] FIG. 1 is a side elevational view of a medical closure screen device embodying the present invention.

[0014] FIG. 2 is an enlarged, fragmentary, side elevational view thereof, taken generally within circle 2 in FIG. 1.

[0015] FIG. 3 is an enlarged, fragmentary, side elevational view thereof, taken generally along line 3-3 in FIG. 2, and particularly showing a barbed strand.

[0016] FIGS. 4a-f show alternative perimeter tube end closures comprising: 4a) subdermal termination; 4b) knotted end; 4c) Leur lock; 4d) transfer element (i.e., sponge); 4e) vacuum source; and 4f) clamped end.

[0017] FIGS. 5a-e show a tissue separation closure procedure embodying the method of the present invention.

[0018] FIG. 6a is an enlarged, fragmentary, cross-sectional view of the closure screen in a tissue separation, with skin hooks shown in hidden lines for positioning the separated tissue portions along the closure screen.

[0019] FIG. 6b is an enlarged, fragmentary, cross-sectional view of the closure screen in a substantially closed tissue separation.

[0020] FIGS. 7a-f show a tissue separation closure procedure embodying the method of the present invention and utilizing optional sponge or foam fluid transfer elements and a tubing placement tool.

[0021] FIG. 8 is a cross-sectional view of a tissue separation closure utilizing tubing for securing the closure screen with a fluid transfer subassembly connected to an upper edge of the closure screen.

[0022] FIG. 9 shows a needle mounting a length of drain tubing and adapted for passing same through tissue.

[0023] FIG. 10 is a side elevational view of a closure screen comprising an alternative embodiment of the present invention, with a perimeter suture.

[0024] FIG. 11a is an enlarged, fragmentary, side elevational view thereof, taken generally within circle 11a in FIG. 10.

[0025] FIG. 11b is an enlarged, fragmentary, side elevational view thereof, showing modified vertical risers.

[0026] FIG. 12 is a side elevational view of a screen-only closure screen comprising an alternative embodiment of the present invention.

[0027] FIG. 13a is an enlarged, fragmentary, side elevational view thereof, taken generally within circle 13a in FIG. 12.

[0028] FIG. 13b is an enlarged, fragmentary, side elevational view thereof, showing modified vertical risers.

[0029] FIGS. 14a-g show a tissue separation closure procedure utilizing the screen-only embodiment of the closure screen.

[0030] FIG. 15a is a side elevational view of a modified vertical riser with flexible, multi-tube risers forming a fluid passage.

[0031] FIG. 15b is a cross-sectional view thereof, taken generally along line 15b-15b in FIG. 15a.

[0032] FIG. 16a is a fragmentary, side elevational view thereof, shown in a compressed configuration.

[0033] FIG. 16b is a cross-sectional view thereof, taken generally along line 16b-16b in FIG. 16a.

[0034] FIG. 17 is a cross-sectional view of another modified vertical riser construction with risers bundled in a different configuration, with barbs.

[0035] FIG. 18 is a cross-sectional view of a modified vertical riser or perimeter element, comprising a fluted tube.

[0036] FIG. 19 is an enlarged, fragmentary, side elevational view of a modified barbed strand configuration.

[0037] FIG. 20 is an enlarged, fragmentary, side elevational view of another modified barbed strand configuration.

[0038] FIG. 21 is an enlarged, cross-sectional view of a closure screen comprising an alternative embodiment of the present invention, with barbs formed by cutting off the ends of looped filaments.

[0039] FIG. 22 is an enlarged, cross-sectional view of a closure screen comprising an alternative embodiment of the present invention, with barbs forming hooks and constructed by cutting looped filaments.

[0040] FIG. 23 is an enlarged, cross-sectional view of a closure screen comprising yet another alternative embodiment of the present invention, with barbs formed by cutting off the ends of looped filaments, which are laid over in a common direction or orientation.

[0041] FIG. 24 is an enlarged, cross-sectional view of a closure screen comprising a further alternative embodiment of the present invention, with barbs forming hooks and constructed by cutting looped filaments, which are laid over in a common direction or orientation.

[0042] FIG. 25 is a perspective view of a closure screen comprising a further alternative embodiment or aspect of the invention, comprising individual links forming flexible strands and including a pre-installation enclosure assembly adapted for holding the screen to length and protectively covering the links.

[0043] FIG. 26 is a perspective view showing the closure screen with the pre-installation enclosure assembly being placed in a tissue separation.

[0044] FIG. 27 is a perspective view showing a pair of the closure screens embedded in a tissue separation, with an excess portion of one of the closure screens being trimmed away.

[0045] FIG. 28 is a perspective view showing a cover strip over the closure screens and the tissue separation.

[0046] FIGS. 29-30 show a sequential procedure for approximating a tissue separation using the closure screen and its enclosure assembly.

[0047] FIG. 31 is a perspective view of another alternative embodiment closure screen.

[0048] FIG. 32 is exploded view thereof.

[0049] FIG. 33 is a perspective view of another alternative embodiment closure screen system.

[0050] FIG. 34 is an exploded view thereof.

[0051] FIGS. 35-46 show approximating tissue separations using a closure screen system embodying the present invention.

[0052] FIG. 47 is a perspective view of an alternative embodiment closure screen, with a partially-exposed, positioning row of prongs.

[0053] FIGS. 48a-c show another alternative embodiment closure screen including a base clip and further show a sequential procedure for approximating separated tissue portions.

[0054] FIG. 49 is a perspective view of another alternative embodiment closure device, comprising discrete closure clips individually mounted on a backing sheet.

[0055] FIG. 50 is a perspective view of yet another alternative embodiment closure device, comprising discrete curved-prong closure clips individually mounted on a backing sheet.

[0056] FIG. 51 is a front view of a patient, particularly showing an abdominal surgical site with a flexible closure screen installed for closing an incision.

[0057] FIG. 52 is a cross-sectional view of the abdominal surgical site with the flexible screen installed in the abdominal cavity in the intraperitoneal position.

Detailed Description of the Preferred Embodiments

I. Introduction and Environment

[0058] As required, detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention in virtually any appropriately detailed structure.

[0059] Certain terminology will be used in the following description for convenience in reference only and will not be limiting. For example, the words “upwardly”, “downwardly”, “rightwardly” and “leftwardly” will refer to directions in the drawings to which reference is made. The words “inwardly” and “outwardly” will refer to directions toward and away from, respectively, the geometric center of the embodiment being described and designated parts thereof The words “horizontal” and “vertical” generally mean side-to-side and top-to-bottom, respectively. Said terminology will include the words specifically mentioned, derivatives thereof and words of a similar import.

[0060] Referring to the drawings in more detail, the reference numeral 2 generally designates a medical closure screen device or system embodying the present invention. Without limitation on the generality of useful applications of the closure screen system 2, the primary application disclosed herein is for assistance with the closing, draining, irrigating and healing of a separation of first and second tissue portions, such as a wound or incision 4. As shown in FIG. 5a, the wound 4 extends from and is open at the dermis 6, through the deep dermal layer 7 and the subcutaneous layer 8, and to approximately the fascia 10. The wound 4 displays edges 12a,b, which correspond to first and second tissue portions. The closure screen device 2 generally comprises a screen 14, a screen perimeter member 16 and an input/output (I/O) subsystem 18.

II. Screen 14

[0061] The screen 14 includes upper and lower margins 20a,b; first and second ends 22a,b; and first and second faces 24a,b. The screen 14 generally forms a grid configuration with vertical, hollow, perforated tubular risers 26 cross-connected by horizontal spacer members 28. Multiple barbed strands 30 are positioned between the risers 26. The risers 26, the spacers 28 and the strands 30 are preferably joined at their respective intersections. As shown in FIG. 3, each strand 30 includes a filament 32 with multiple, pointed barbs 34 extending upwardly and outwardly on both sides in staggered, spaced relation. The barbs 34 generally project outwardly from the screen faces 24a,b, for purposes which will be described in more detail hereinafter.

[0062] The screen or mesh 14 material can be either dissolvable (absorbable) or non-dissolvable (non-absorbable) and can be chosen from a number of commercially-available, biocompatible products, which are commonly used in medical applications for sutures, implantable meshes, and similar medical devices.

[0063] Examples of absorbable materials include, but are not limited to: aliphatic polyesters, which include, but are not limited to: homo polymers and copolymers of lactide, .epsilon.-caprolactone, p-dioxanone, trimethylene carbonate, alkyl derivatives of trimethylene carbonate, .delta.-hydroxyvalerate, 1,4-dioxepan-2-one, 1,5-dioxepan-2-one, 6,6-dimethyl-1,4-dioxan-2-one and polymer blends thereof. Examples of nonabsorbable materials include, but are not limited to: cotton, linen, silk, polyamides, polyesters, fluoropolymers, polyolefins, polyethylene, metals and combinations thereof.

III. Screen Perimeter Member 16

[0064] The optional screen perimeter member 16 can comprise, for example, a flexible, perforated, hollow tube 35 with multiple orifices 36. As shown in FIG. 1, the tube 35 includes first and second legs 38, 40 extending generally along the screen first and second ends 22a,b, and a base leg 41 extending generally along the screen lower margin 20b. The tubing first and second legs 38, 40 terminate in respective first and second ends 38a, 40a. The tube 35 can be secured to the screen 14 by multiple ties 42, which can comprise extensions of the horizontal spacer members 28 and the strands 30. By providing dissolvable ties 42, the tube 35 can be designed for separation from the remainder of the closure screen 2 after a relatively short period of time. For example, the dissolvable material can dissolve into the patient's body after a few days, whereafter the tube 35 can be removed.

[0065] Optionally, portions of the tube 35 can be cut away from the screen 14. For example, the screen 14 can be separated along each screen end 22a,b, or it can be separated completely from the tube 35. In this manner the screen 14 and the tube 35 can be configured to accommodate a variety of conditions and tissue separation configurations.

[0066] The vertical risers 26 are optionally fluidically coupled to the tube 35 at respective T intersections 44. In this configuration the tube 35 and the vertical risers 26 cooperate to provide a manifold for fluid handling, i.e. either extraction or irrigation, as indicated by the fluid flow arrows 45.

IV. Input/Output (I/O) Subsystem 18

[0067] The input/output subsystem 18 is designed for extraction and/or irrigation of the patient's bodily fluids and/or external fluids. As shown in FIG. 1, the input/output subsystem 18 includes first and second I/O devices 18a,b attached to the tubing first and second leg ends 38a,b, which in this configuration are considered the “port” ends of the tube 35. One or both of the I/O devices 18a,b can comprise a pressure differential source, such as the NPWT device, The V.A.C.® System™, available from Kinetic Concepts, Inc. of San Antonio, Tex. The use of such units for wound treatment and fluid management is disclosed in the Zamierowski U.S. Pat. No. 4,969,880; U.S. Pat. No. 5,100,396; U.S. Pat. No. 5,261,893; U.S. Pat. No. 5,527,293; and U.S. Pat. No. 6,071,267, which are incorporated herein by reference.

[0068] Alternatively, the tubing port ends 38a,b can be connected to various other sources of pressure differential and various drainage and irrigation devices. For example, they can be cut short below the dermis 6 and left within the separation 4 for sealing by the adjacent tissue portions 12a,b. FIG. 4a shows a truncated tubing end 38b. The tubing ends 38a/40a can be knotted (as shown at 48 in FIG. 4b), clipped, tied (e.g., with a suture) or otherwise closed off either above or below the dermis 6. FIG. 4c shows a Leur lock coupling 46 mounted on a tubing end 38a/40a. Still further, a transfer element comprising a piece of foam or sponge 50 can be coupled to the tube 35 at an end 38a/40a (FIG. 4d). Examples of such foam and sponge materials and configurations are discussed in the Zanierowski U.S. patents identified above. A pressure differential source, such as a vacuum source 51, can be connected to a tube end 38a/40a and to a fluid receptacle 66, as shown in FIG. 4e. A clamp 62 is shown in FIG. 4f and closes the tube end 38a/40a. The clamp 62 can be chosen from among several suitable clamps, which are commonly used for medical applications.

[0069] Either tube end 38a/40a can function as either an inlet port or an outlet port with respect to the system 2. For example, suction can be applied for pulling fluid from the patient through the system 2 through either tube end 38a/40a. Still further, fluid can be pulled in both directions through the system 2 by alternately or jointly applying suction to the tube ends 38a/40a. For example, suction can be simultaneously applied to both tube ends 38a/40a.

V. Operation And Closure Method

[0070] FIGS. 5a-e show an installation methodology utilizing the system 2 of the present invention. In FIG. 5a, the closure screen 2 is placed in the separation 4 with the tubing base 41 located at the bottom of the separation (e.g., wound or incision) 4 and in proximity to the fascia layer 10. As shown, the tissue portions or wound/incision edges 12a,b are spaced apart. The screen upper margin 20a can protrude outwardly from the dermis 6. FIG. 5b shows the tissue separation edges 12 being pushed together as indicated by the force arrows 52. FIG. 5c shows the separation edges 12 engaged at the dermis 6, and spaced apart somewhat within the subcutaneous layer 8. The edges 12 can be pushed together as indicated by the force arrows 52. Moreover, the screen 2 can be held or positioned inwardly in order to advance the barbs 34 in the separation edges 12, as indicated by the inward or downward force arrows 54a. FIG. 5d shows the separation edges 12a,b substantially closed on the screen 2. Tugging on the screen 14 in the general direction of the outward force arrow 54b sets the mesh barbs 34.

[0071] FIG. 5e shows the separation 4 closed on the closure screen 2, with the tubing 35 removed from the screen 14. The tubing 35 can be removed either pre-installation by cutting the ties 42, or post-installation by allowing the ties 42 to dissolve, whereafter the unsecured tubing 35 can be extracted.

[0072] FIG. 6a shows the barbs 34 compressed by engagement with the separation edges 12a,b. As shown, the separation edges 12 can be manually closed by pressing along the horizontal force arrows 52. The barbs 34 allow the separation edges 12a,b to slide upwardly or outwardly along the screen 14. This process can be repeated until the separation 4 is closed, as shown in FIG. 6b. Any protruding length of the screen 14 can be cut close to the dermis 6. In the final configuration (FIGS. 5e and 6b), the barbs 34 are embedded in the tissue adjacent to the separation edges 12a,b and thus secure the separation 4 in a closed position. The fluid conducting properties of the screen 14 facilitate extracting fluid. An outward or upward force arrow 54b indicates a force direction whereby the screen barbs 34 are set in the adjoining tissue. It will be appreciated that the screen 14 can be securely set in place with the barbs 34, yet the separation edges 12a,b will remain capable of sliding up on the screen 14 by disengaging the barbs 34 with lateral forces, as shown in FIG. 6a. Skin hooks 55 can be used for engaging the tissue portions 12a,b and tugging same outwardly as shown in FIG. 6a. The skin hooks 55 can facilitate positioning and repositioning the screen 14.

VI. Alternative Embodiment Closure Screen Systems and Methodologies

[0073] FIGS. 7a-f show an alternative procedure for mounting the closure screen 2 in a wound drainage application utilizing pressure differential. As shown in FIG. 7a, the tubing 35 can pass through the tissue adjacent to the wound 4 and exit the dermis 6 for termination of the tubing end 38a/40a as described above. An optional layer of a suitable, biocompatible adhesive 64 is shown applied to the closure screen first face 24a for securing same to the first wound edge 12a. FIG. 7b shows the screen 14 extending upwardly from the dermis 6 with the wound edges 12a,b brought together in a manner similar to that described above.

[0074] The input/output subsystem 18 includes a pair of optional fluid transfer elements comprising foam or sponge members 56a,b placed on the dermis 6 on either side of a protruding portion 14a of the screen 14. The screen 14 is then cut to a level generally flush with the upper surfaces of the sponges 56a,b, as shown in FIG. 7c. An optional sponge bridge 58 is placed over the sponge members 56a,b (FIG. 7d). Examples of suitable transfer element materials are discussed in the Zamierowski patents noted above and include open-cell, porous foam materials (e. g., polyurethane ester (PUE)) chosen for their hydrophobic properties and passage of liquids. Polyvinyl acetate (PVA) material can be used for its hydrophilic properties. The transfer element subassembly 59 formed by the sponge members 56a,b and 58 can be connected to a vacuum source, a fluid irrigation source, etc. Moreover, it can be connected to additional fluid transfer elements and covered with various flexible membranes and drapes, which can be semi-permeable or impervious, as indicated for the closure and treatment of particular separations and wounds.

[0075] FIG. 7e shows a tubing placement tool 120 with a handle 122, a shaft 124 and a hook 126 terminating at a pointed or rounded, bullet-shaped tip 128. FIG. 7f shows the tool 120 passing tubing 35 through tissue in the subcutaneous layer 8 and into proximity with the dermis 6. The tip 128 is received in a blind end 134 of the tubing 35 through a notch 136 formed therein. The thrust of the tool 120 causes tenting of the dermis 6, as shown at 138, whereat the dermis 6 can be opened with a scalpel 140 and the tubing 35 can exit the patient for suitable termination arrangements, such as those shown in FIGS. 4a-f above.

[0076] FIG. 8 shows a modified embodiment closure system 202 with a pair of screens 14 positioned generally end-to-end in a separation 204. A transfer element subassembly 59 is placed over the separation 204 and a membrane drape 205 is placed thereover. The tube 35 is passed through tissue on either side of the separation 204 (e.g., using the procedure and the tubing placement tool 120 described above) and exits the dermis 6 on either side of the transfer element subassembly 59. The tube 35 lengths are knotted at 206. The tube 35 lengths thus function as sutures or retainers for securing the closure system 202 in the separation 204. The tube ends 38a or 40a can be utilized for this purpose, thus leaving the other tubing ends available for fluid communication with one or more of the input/output subsystems 18 described above.

[0077] The tube 35 can be secured by suitable fasteners, such as clips and the like, located above the dermis 6. Moreover, the screens 14 can be overlapped, abutted, spaced slightly and otherwise configured and positioned as necessary for particular tissue separations. Still further, the screens 14 are adapted to be trimmed as necessary.

[0078] FIG. 9 shows a modified embodiment tubing/suture subassembly 220 with a Trocar instrument 222 including a sharpened, distal end 224 and a proximate end 226 with multiple, annular ridges 226a. A length of flexible tubing 228 combines the functions of screen perimeter member and suture. The flexible tubing 228 terminates at an end 228a adapted for releasably mounting on the needle proximate end 226, whereat it is retained in place by the ridges 226a. The tubing 228 is optionally connected to the screen 14 as described above and can include perforations 228b for fluid drainage and/or irrigation in conjunction with input/output subsystems 18, also as described above. The tubing/suture subassembly 220 is adapted for securing the screen 14 in place and for closing the separation 4 by passing the tubing 228 through adjacent tissue. The tubing/suture subassembly 220 and the screen 14 can be prepackaged and presterilized for closing and treating separations, which can include wounds and incisions.

[0079] FIGS. 10, 11a and 11b show modified embodiment closure screen systems 302 with first and second suture subassemblies 304, 306 comprising the screen perimeter member. The suture subassemblies 304, 306 include respective curved needles 304a, 306a which are swaged or adhesively connected to opposite ends 304b, 306b of a common length of suture thread 307. The suture thread 307 can be absorbable or nonabsorbable. As shown in FIG. 10, the screen closure system 302 can be preassembled with the suture thread length 307 releasably secured to the perimeter 308a of a screen 308. Prior to installation of the screen 308, the suture 307 can be disconnected or severed therefrom, either partly or completely. For example, the suture 307 can be separated along the screen ends 310a, 310b respectively, thereby leaving the suture thread lengths secured only along a screen lower margin 312.

[0080] In operation, the suture subassemblies 304, 306 facilitate installation of the suture/screen closure system 302, thereby providing a preassembled device which incorporates the necessary components for securing same in a separation 4. For example, the screen 308 can be secured at the bottom alone by passing the suture subassemblies 304, 306 through tissue portions located at the bottom of the separation 4. Alternatively, the suture subassemblies 304, 306 can be passed through the adjacent tissue and exit the surface of the dermis 6, whereby the suture subassemblies 304, 306 can be used for closing the separation 4 at the dermis 6. Barbed strands 320 can interact with the tissue portions 12a,b as described above, whereby the screen 308 provides a relatively secure mechanical connection between the separated tissue portions 12a,b. The suture subassemblies 304, 306 can be utilized for various purposes in the separation 4, including attachment and tacking of the dermis 6, the deep dermal layer 7, the subcutaneous layer 8 and the fascia 10. Still further, all or part of the suture subassemblies 304, 306 can be removed, and additional suture subassemblies can be mounted on or sutured to the screen 308.

[0081] FIG. 11a shows the screen 308 attached to the suture thread 307. FIG. 11b shows an alternative construction screen 318 with hollow tubular vertical risers 324 located between adjacent, respective vertical strands 320, all connected by the spacers 322 and adapted for communicating fluid with the separation 4 through the open riser ends 324a and the perforations 324b, as indicated by the fluid flow arrows 326. All or part of the screen/suture system 302 can comprise absorbable material.

[0082] FIGS. 12, 13a and 13b show a modified embodiment screen-only closure screen system 402 and application methodology. A screen or mesh 404, similar to the screen 14 with barbed strands 30 described above, is placed in a separation 4 against the first tissue portion 12a. The second tissue portion 12b is then placed against the screen 404 whereby the separation 4 is closed and can be secured by the mechanical action of the screen 404. The screen 404 can be supplemented with sutures, drainage tubing, I/O devices, and other auxiliary components for purposes of closing the wound edges 12, draining the inside of the tissue separation 4, fighting infection, pain management and all other functionalities associated with the present invention, as discussed elsewhere herein. For example, the screen 404 can be secured with sutures at the subcutaneous level 8. Various fluid interconnecting devices can be utilized as necessary, and can be designed for removal after they serve their initial purpose. External drainage can also be achieved at the dermis level 6 utilizing transfer element subassemblies, such as the example designated 59 and described above (FIG. 7d). Moreover, drainage and irrigation tubing can be installed within the wound 4 alongside or adjacent to the screen 404. It will be appreciated that a screen-only version of the invention can comprise various suitable biocompatible absorbable and non-absorbable materials, including the materials disclosed above.

[0083] FIG. 13a is an enlarged view of the screen 404 and particularly shows barbed strands 406 and horizontal spacers 408, which are connected together in a grid pattern forming the screen 404. FIG. 13b shows an alternative embodiment with a modified screen 410 including vertical risers 412 comprising hollow tubing, which are connected to and spaced by horizontal spacers 408. Fluid flows into and out of the vertical risers 412 through open riser ends 412a and perforations 412b, as indicated by the fluid flow arrows 420.

[0084] FIGS. 14a-g show the screen 404 installed in a tissue separation 4 and closing same, utilizing the methodology of the present invention. The methodology shown in FIGS. 14a-g is similar to the methodology shown in FIGS. 5a-e and 6a,b. FIG. 14c shows a downward/inward force arrow 54a indicating a direction in which the screen 404 is pushed or guided into the separation.

[0085] FIGS. 15a,b and 16a,b show a modified vertical riser 502 comprising bundled tubes 504 secured together at spaced intervals by connectors 506. The normal movement of the patient tends to alternately compress and expand the vertical risers 502, thus providing a “pumping” action for transferring fluid from the wound 4, as indicated by the fluid flow arrows 510. FIGS. 15a,b show a riser 502 in an extended configuration. Compressing the screen 14 longitudinally (i.e., end-to-end) compresses the bundled risers 504 to the configuration shown in FIGS. 16a,b, whereby fluid is drawn into the interstitial space 508 and pumped therefrom when the risers 502 extend.

[0086] FIG. 17 shows yet another configuration of a vertical riser 602 with bundled tubes 604, which are closely bunched and define passages 606 for conveying fluid. Such fluid conveyance can be enhanced by a pumping action associated with normal patient movements. Barbs 608 project outwardly from the tubes 604. It will be appreciated that various other bundled tube configurations, such as twisted, braided, etc., can be utilized.

[0087] FIG. 18 shows yet another vertical riser/perimeter member 702 alternative embodiment configuration. The member 702 has a configuration which is commonly referred to as a “fluted” drain and includes longitudinally-extending passages 704. This configuration can substitute for the perimeter members described above and can function to communicate fluid to and from the wound 4 with the input/output subsystem 18.

[0088] As additional alternative embodiment configurations for the vertical risers, they can comprise either barbed monofilament strands, similar to strand 30 shown in FIG. 3, or unbarbed monofilament strands. Such monofilament vertical risers can function as passive drains with fluid flowing alongside same. They can extend above the dermis 6 and abut or connect to transfer elements formed in various configurations with suitable absorbent materials. Examples include gauze dressings and transfer element subassemblies, such as 59 shown in FIG. 7d.

[0089] FIG. 19 shows an alternative embodiment strand 802 constructed by twisting and braiding multiple, individual filaments 804. Barbs 805 are formed by respective individual filaments 804a, which terminate at blunt ends 806. The barbs 805 project generally outwardly from the strand 802 and form acute angles with respect to its longitudinal axis. They are adapted for penetrating tissue within a separation 4, as described above. In use, the barbs 805 would normally be oriented in directions generally pointing outwardly from the patient and the tissue separation 4.

[0090] FIG. 20 shows another alternative embodiment strand 902 comprising multiple twisted and braided filaments 904. Barbs 905 are formed from individual filaments 904a and have notches 908 and pointed ends 910. The notches 908 and the ends 910 are configured to allow the barbs 905 to easily extract from the separation edge tissues, whereby the screen is adapted for sliding along the separation edges in order to achieve the proper position.

[0091] FIG. 21 shows a further modified screen 1002 with barbs 1004 formed by looping individual filaments 1006 and cutting same at cut locations 1010 spaced inwardly from respective apexes 1008 of the filament loops. In operation, the barbs 1004 slightly penetrate the tissue and are imbedded therein. It will be appreciated that the filaments 1006 are relatively thin in diameter, similar to microfibers, whereby patient comfort is optimized.

[0092] FIG. 22 shows yet another modified screen 1102 with barbs 1104 formed by looping individual filaments 1106 and cutting same at locations 1110 spaced inwardly from respective apexes 1108 of the filament loops whereby respective hooks 1112 are formed. The hooks 1112 operate in a manner similar to hook-and-loop fasteners, with the adjacent tissue forming the loop parts of the connections. In operation, the hooks 1112 slightly penetrate the tissue and are imbedded therein. The configurations of the hooks 1112 tend to retain them in the tissue adjacent to the separation 4 whereby the separated first and second tissue portions 12a,b can be closed.

[0093] FIG. 23 shows a screen 1202 with a configuration similar to the screen 1002 discussed above, with additional fiber elements or filaments 1204. The additional filaments 1204 tend to lay the filament barbs 1206 over whereby the screen 1202 can be directionally oriented within the wound separation 4 and operate in a manner similar to the screen 14 described above. The barbs 1206 are formed by cutting the apexes 1208 at cut locations 1210.

[0094] Similarly, FIG. 24 shows a screen 1302 with additional filaments 1304, which engage the filament loops 1306 and orient same in a direction towards the right as shown in FIG. 24. The slanted orientations of the filament loops 1306 facilitate setting same in the tissue portions 12a,b adjacent to the separation 4 by tugging outwardly on the screen 1302. Repositioning the screen 1302 is also possible, as described above. The filament loops 1306 can be cut at cut locations 1310, which are spaced inwardly from filament loop apexes 1308 whereby hooks 1312 are formed.

[0095] It will be appreciated that FIGS. 21-24 disclose screens with barbs and hooks extending from one face thereof. The present invention also includes screens with barbs and hooks extending from both faces.

[0096] A closure screen comprising a further modified aspect or embodiment of the invention is shown in FIGS. 25-30 and is generally designated by the reference numeral 1402. The screen 1402 generally comprises a highly flexible panel 1404, which engages and approximates adjacent tissue portions across a separation by the semi-independent action of multiple, individual links 1406, which are strung together in respective strands 1408.

[0097] The screen 1402 includes a pre-installation enclosure assembly 1424 comprising front and back backing sheets 1426, 1428, which can be provided with a suitable releasable adhesive 1429. The backing sheets 1426, 1428 preferably comprise paper or other material (e.g., Styrofoam® material), which is relatively stiff (as compared to the relatively flimsy panel 1404) for maintaining the flat shape of the closure screen 1402 during handling and placement in the patient and for protection from the sharpened prong tips. An outer edge handling strip 1430 is mounted on the upper edge of perimeter 1432 of the panel 1404 (FIG. 25) and is adapted for grasping manually or with instruments in order to facilitate handling, alignment and placement.

[0098] FIG. 26 shows a closure screen 1402 being placed in a tissue separation 4 with a suitable instrument, such as forceps 1434. FIG. 27 shows the panels 1404 of two closure screens 1402 in place with the backing pieces 1426 and 1428 removed and with the separated tissue portions 12a,b pushed together and approximated by the panels 1404. Selvage edges 1436 can be trimmed flush with the skin surface and removed along with the handling strips 1430. The closed separation 4 can be covered with a suitable cover strip 1438, which can provide tensile retaining strength for securing the tissue portions 12a,b together, as well as protecting the separation 4 during healing (FIG. 28).

[0099] FIG. 29 shows a closure screen 1502 in place in a tissue separation 4. FIG. 30 shows extracting a back backing sheet 1508, whereby the panel 1504 is placed against the tissue portion 12b for engaging same by penetrating its prongs into the tissue approximately 1-2 mm or whatever length is dictated by particular tissue requirements.

[0100] FIGS. 31-46 show the construction and operation of another modified embodiment or aspect of a closure screen 1502 embodying the present invention. FIG. 31 shows the closure screen 1502 assembled, with front and back backing sheets 1506, 1508 enclosing a tissue approximation panel 1504. FIG. 32 is an exploded view thereof, with the tissue approximation panel 1504 adapted for placement between the front and back backing sheets 1506, 1508. The backing sheets 1506, 1508 have upper margins 1510, 1512 respectively, with the back backing sheet upper margin 1512 extending higher than the front backing sheet upper margin 1510, which facilitates gripping the back sheet 1508 at its upper margin 1512 with forceps or some other similar instrument. The back backing sheet upper margin 1512 is preferably printed with a color for high visibility, to further facilitate grasping same with forceps or manually. FIGS. 33 and 34 show another embodiment closure screen 1513 with a square closure panel 1514 with a similar construction to the rectangular panel 1504.

[0101] FIG. 35 shows the tissue separation 4 with first and second separated tissue portions or edges 12a,b. FIG. 36 shows the placement of a closure screen 1513 with dashed lines indicating panels 1514, which are already in place in the tissue separation 4. As shown in FIG. 36, a tissue separation 4 can be “tiled” with the closure panels 1514, which can be of any suitable size and number depending upon the configuration of the separation 4. FIG. 37 shows the screen 1502 (FIG. 31) in place with its back backing sheet 1508 removed, whereby the prongs are exposed to and penetrate the tissue portion 12b. The opposite tissue portion 12a can be pushed in the direction of directional arrow 1516 to approximate closure. FIG. 38 shows the lower (innermost) portion of the tissue separation 4 approximated, with the front backing sheet 1506 being removed in FIG. 39, resulting in the condition shown in FIG. 40 with the lower portion of the tissue separation 4 secured or “approximated” against the closure panel 1504. FIGS. 41-46 show securing an upper (or outer/distal) portion of the tissue separation 4 with another closure screen 1502 by essentially repeating the procedure described above. A protruding distal selvage margin 1518 is removed from the outermost panel 1504 as shown in FIG. 44 substantially flush with the skin surface. A suitable cover 1520 is placed over the tissue separation as shown in FIG. 45. FIG. 46 shows the prong-tissue engagement whereby the tissue edges 12a,b are approximated, with the upwardly-and-outwardly orientation of the prongs 1522 tending to draw together at the tissue edges 12a,b in response to outward tugging on the panel 1504. The prongs of the various embodiment closure screens and clips can have various suitable sizes and configurations, including curved, straight, barbed, etc. Closure and approximation of the tissue separation 4 can be augmented with tape, adhesive, staples, sutures or other closure devices, including a pressure differential source, such as the NPWT device, The V.A.C.® System™, available from Kinetic Concepts, Inc. of San Antonio, Tex., which can be chosen to promote wound closure in conjunction with a closure screen or screens.

[0102] FIG. 47 shows another alternative embodiment closure screen 2302 with a backing sheet 2304 having a lower removable strip 2306, which exposes a lowermost row 2308 of clips for initially positioning the screen 2302, whereafter an upper portion 2310 of the backing sheet 2304 can be removed.

[0103] FIGS. 48a-c show another embodiment closure screen 2352 with a row of closure clips 2354, which can be mounted along a bottom edge 2356 of a panel 2358 of the closure screen 2352. Each closure clip 2354 includes first and second rows of laterally-projecting hooks 2360a,b, which are adapted and positioned for penetrating respective tissue portions 12a,b. A sequential procedure for closing a lower or inner portion of a tissue separation 4 can begin with the closure clips 2354 positioned within the tissue separation 4 as shown in FIG. 48a. The first row of hooks 2360a can be embedded in the first tissue portion 12a, for example by tilting and manipulating the panel 2358 (FIG. 48b). Closure can be accomplished by embedding the second row of hooks 2360b in the second separated tissue portion 12b (FIG. 48c), for example, by tilting and manipulating the panel 2358. The closure screen 2352 with the closure clips 2354 can be used in conjunction with the enclosure assembly of the closure screen 2302, whereby the lower row of links 2308 can be exposed for supplementing the closure clips 2354 in connection with initially anchoring the closure screen. The clips 2354 can be provided in any suitable number and spacing, including a clip 2354 at the lower end of each column of links, at the lower end of every other column of links, etc.

[0104] FIG. 49 shows an additional alternative embodiment closure screen 2402, which is constructed by mounting discrete clips 2404 on a backing 2406, which can retain the clips 2404 by a suitable adhesive or some other means pre-installation. FIG. 50 shows yet another alternative embodiment closure screen 2502, which is similar to the screen 2402 but with fewer and different clips 2504. The clips 2504 have prongs 2506, which are curved in an outwardly-convex direction with respect to bodies 2508 of the clips 2504. The curvature of the prongs 2506 can facilitate penetration and closure of the separated tissue portions 12a,b. The prongs 2506 can also be straight, barbed, etc., and can be oriented at any suitable angle with respect to the bodies 2508 of the clips 2504.

[0105] FIGS. 51 and 52 show a closure screen 1902 applied to an abdominal incision 1904. Such incisions are typically involved in abdominal surgery procedures and can result in various complications, including infection and difficulties in closure and healing. The abdominal tissues are exposed within the abdominal cavity to a perimeter 1906. The screen 1902 can be provided with multiple rigid or semi-rigid non-collapsible members 1908 for maintaining its general shape and facilitating its placement in the abdominal cavity, preferably to approximately the perimeter 1906. The screen 1902 includes a panel with opposite faces and multiple prongs projecting from said faces. The prongs 1910 can be oppositely-oriented towards a medial line or centerline 1916 for directing the opposite sidcs of the incision 1904 towards medial closure. The medial line or centerline 1916 divides the panel into first and second portions. The screen 1902 can be provided with a perimeter member 1912. which is preferably sized and configured to place and maintain the screen in proximity to the tissue separation perimeter 1906. Relatively extensive coverage of the abdominal tissue separation can thus be achieved, particularly with the positioning effects of the non-collapsible members 1908 and the perimeter member 1912 in combination. A pre-installation enclosure assembly including front and back backing sheets can be mounted on opposite sides of the screen 1902 pre-installation, for removal to expose the prongs 1910 for engaging the tissue portions. The screen 1902 can be positioned between abdominal tissue layers with the medial line or centerline 1916 located below the abdominal incision. The panel can then be pulled at the medial line or centerline 1916 in order to further embed the prongs 1910 and close the incision by pulling the tissue edges together with the panel. With appropriate dissection and direction of prongs, this device can also be placed in pre-peritoneal positions and on the musculature, in addition to placement intra-abdominally between the musculature and an inner tissue layer 1914, as shown in FIG. 52.

[0106] It is to be understood that while certain forms of the present invention have been illustrated and described herein, it is not to be limited to the specific forms or arrangement of parts described and shown.

Claims

Having thus described the invention, what is claimed as new and desired to be secured by Letters Patent is:

1. A primary intention healing medical closure method for closing a wound comprising a separation of first and second tissue portions, which method comprises the steps of:

said first and second tissue portions presenting respective first and second tissue edges, which extend into a depth of the wound including at least a subcutaneous layer;

providing multiple flexible screens with outwardly-projecting prongs;

configuring said prongs for retaining said tissue thereon;

configuring each said screen for placement in said tissue separation;

placing each said screen in said tissue separation and penetrating at least one of said tissue portions at the subcutaneous layer with said prongs;

closing said tissue separation;

providing each said screen with multiple, discrete clips having constructions chosen from among the list consisting of: stamped sheet metal; bioabsorbable; formed wire;

plastic; barbed-prong: and curved-prong;

providing each said clip with at least one of said prongs;

providing each said screen with a panel comprising a flexible matrix mounting said clips;

forming said matrix with multiple, flexible interwoven filaments;

providing each said screen with a pre-installation enclosure assembly with front and back backing sheets mounted on opposite sides of said panel pre-installation;

removing said backing sheets from each said screen exposing said prongs and engaging said tissue portions with said prongs;

installing multiple said panels in said tissue separation;

locating at least some of said panels adjacent to a skin surface with outer edges of said panels located exteriorly to the patient;

covering said tissue separation with a dressing applied to the skin surface;

providing a vacuum source;

providing a tube;

fluidically connecting at least some of said screens with said vacuum source via said tube;

applying a negative pressure to said screens and thereby extending a vacuum into the depth of the wound to said tissue separation;

draining said tissue separation with negative pressure; and

closing said tissue separation by holding said tissue edges together substantially throughout said wound with negative pressure in combination with said panels.

2. A primary intention method of closing an abdominal incision wound, which includes the steps of:

forming with said abdominal incision first and second tissue portions;

said first and second tissue portions presenting respective first and second tissue edges, which extend into a depth of the wound between first and second abdominal tissue layers;

providing a closure screen with a generally flat panel including opposite faces, multiple prongs projecting from said faces and a perimeter;

providing said panel with first and second portions and a medial line dividing said first and second portions;

orienting said prongs at said first and second portions oppositely towards said medial line;

placing said panel between first and second tissue edges exposed by said abdominal incision with said panel positioned in an orientation with said panel faces generally parallel to a skin surface and with said medial line thereof located below said abdominal incision:

penetrating said tissue edges layers with said prongs;

applying tension to said panel at said medial line with a pulling force:

further embedding said prongs with said pulling force on said panel;

primary intention closing said incision with said pulling force on said panel;

providing a vacuum source;

providing a tube;

fluidically connecting said screen with said vacuum source via said tube;

applying a negative pressure extending a vacuum into the depth of said incision wound via said panel;

draining said tissue separation with negative pressure; and

closing said tissue separation by holding said tissue edges together substantially throughout said wound with negative pressure in combination with said panel.

3. The method according to claim 2, which includes the additional steps of:

providing said panel with a flexible, semi-rigid perimeter member at said perimeter;

locating said perimeter member at a perimeter of said abdominal tissue layer separation; and

maintaining the shape of said panel with said perimeter member.

4. The method according to claim 2, which includes the additional steps of:

providing said panel with multiple semi-rigid, non-collapsible members oriented longitudinally, transversely or diagonally with respect to said panel; and

maintaining the shape of said panel with said members.

5. The method according to claim 2, which includes the additional step of placing the panel in a pre-peritoneal position on the abdominal musculature.

6. The method according to claim 2, which includes the additional step of placing the screen intra-abdominally below the abdominal musculature.

7. The method of claim 2, which includes the additional steps of:

providing multiple clips and providing each said clip with a body and multiple said prongs extending therefrom;

providing a pre-installation enclosure assembly with front and back backing sheets mounted on opposite sides of said screen pre-installation; and

removing said backing sheets from said screen, exposing said prongs and engaging said tissue portions with said prongs.

8. A primary intention medical closure method for closing a wound comprising a separation of first and second tissue portions, which method comprises the steps of:

said first and second tissue portions presenting respective first and second tissue edges, which extend into a depth of the wound including at least a subcutaneous layer;

providing multiple flexible panels;

providing each said panel with an inner edge;

providing each said panel with first and second faces;

providing each said panel with multiple pronged clips;

providing each said pronged clip with at least one outwardly-projecting, distally-oriented prong;

providing each said panel with a flexible matrix mounting said pronged clips;

extending said prongs from the first and second faces of each said panel;

distally orienting said prongs away from respective panel inner edges;

forming each said matrix with multiple, flexible interwoven filaments;

providing at least one of said panels with a row of base clips along said inner edge;

providing each said base clip with first and second hooks with larger and thicker configurations than said prongs;

proximally orienting said hooks away from said at least one panel inner edge, oppositely to said prongs;

placing said at least one panel with base clips in said separation;

initially anchoring said panel and initially closing said tissue separation by penetrating an inner tissue layer at said first and second tissue edges with said hooks in a non-repositionable engagement;

placing other panels with pronged clips in said separation distally from said panel with base clips;

further closing said tissue separation distally from said inner tissue layer by penetrating an outer tissue layer at said tirst and second tissue edges with said prongs in a repositionable engagement;

locating at least one of said panels adjacent to the skin surface with an outer edge of said panel located exteriorly to the patient and forming a protruding portion; and

covering said tissue separation with a dressing applied to the skin surface;

providing a vacuum source;

providing a tube;

fluidically connecting at least some of said panels with said vacuum source via said tube;

applying a negative pressure to said panels and thereby extending a vacuum into the depth of the wound to said tissue separation;

draining said tissue separation with negative pressure; and

closing said tissue separation by holding said tissue edges together substantially throughout said wound with said negative pressure in combination with said panels.

Patent Citations (199)

Patent	Date	Inventor	Cited By
US221427(A)	1879-11-01	Sherman	Applicant
US1355846(A)	1920-10-01	Rannells	Applicant
US2547758(A)	1951-04-01	Keeling	Applicant
US2632443(A)	1953-03-01	Lesher	Applicant
US2682873(A)	1954-07-01	Evans et al.	Applicant
US2969057(A)	1961-01-01	Simmons	Applicant
US3066672(A)	1962-12-01	Crosby, Jr. et al.	Applicant
US3115138(A)	1963-12-01	McEvenny et al.	Applicant
US3367332(A)	1968-02-01	Groves	Applicant
US3520300(A)	1970-07-01	Flower Jr.	Applicant
US3648692(A)	1972-03-01	Wheeler	Applicant
US3682180(A)	1972-08-01	McFarlane	Applicant
US3826254(A)	1974-07-01	Mellor	Applicant
US3981051(A)	1976-09-01	Brumlik	Applicant
US4080970(A)	1978-03-01	Miller	Applicant
US4096853(A)	1978-06-01	Weigand	Applicant
US4139004(A)	1979-02-01	Gonzalez, Jr.	Applicant
US4165748(A)	1979-08-01	Johnson	Applicant
US4233969(A)	1980-11-01	Lock et al.	Applicant
US4245630(A)	1981-01-01	Lloyd et al.	Applicant
US4248232(A)	1981-02-01	Engelbrecht et al.	Applicant
US4259959(A)	1981-04-01	Walker	Applicant
US4261363(A)	1981-04-01	Russo	Applicant
US4275721(A)	1981-06-01	Olson	Applicant
US4284079(A)	1981-08-01	Adair	Applicant
US4297995(A)	1981-11-01	Golub	Applicant
US4333468(A)	1982-06-01	Geist	Applicant
US4373519(A)	1983-02-01	Errede et al.	Applicant
US4382441(A)	1983-05-01	Svedman et al.	Applicant
US4392853(A)	1983-07-01	Muto	Applicant
US4392858(A)	1983-07-01	George et al.	Applicant
US4419093(A)	1983-12-01	Deaton	Applicant
US4419097(A)	1983-12-01	Rowland	Applicant
US4475909(A)	1984-10-01	Eisenberg	Applicant
US4480638(A)	1984-11-01	Schmid	Applicant
US4525166(A)	1985-06-01	Leclerc	Applicant
US4525374(A)	1985-06-01	Vaillancourt	Applicant
US4540412(A)	1985-09-01	Van Overloop	Applicant
US4543100(A)	1985-09-01	Brodsky	Applicant
US4548202(A)	1985-10-01	Duncan	Applicant
US4551139(A)	1985-11-01	Plaas et al.	Applicant
US4569348(A)	1986-02-01	Hasslinger	Applicant
US4605339(A)	1986-08-01	Bullivant	Applicant
US4605399(A)	1986-08-01	Weston et al.	Applicant
US4608041(A)	1986-08-01	Nielsen	Applicant
US4640688(A)	1987-02-01	Hauser	Applicant
US4655754(A)	1987-04-01	Richmond et al.	Applicant
US4696301(A)	1987-09-01	Barabe	Applicant
US4710165(A)	1987-12-01	McNeil et al.	Applicant
US4733659(A)	1988-03-01	Edenbaum et al.	Applicant
US4743232(A)	1988-05-01	Kruger	Applicant
US4758220(A)	1988-07-01	Sundblom et al.	Applicant
US4775909(A)	1988-10-01	Inoue et al.	Applicant
US4787888(A)	1988-11-01	Fox	Applicant
US4826494(A)	1989-05-01	Richmond et al.	Applicant
US4828546(A)	1989-05-01	McNeil et al.	Applicant
US4838883(A)	1989-06-01	Matsuura	Applicant
US4840187(A)	1989-06-01	Brazier	Applicant
US4863449(A)	1989-09-01	Therriault et al.	Applicant
US4872450(A)	1989-10-01	Austad	Applicant
US4878901(A)	1989-11-01	Sachse	Applicant
US4897081(A)	1990-01-01	Poirier et al.	Applicant
US4906233(A)	1990-03-01	Moriuchi et al.	Applicant
US4906240(A)	1990-03-01	Reed et al.	Applicant
US4919654(A)	1990-04-01	Kalt	Applicant
US4941882(A)	1990-07-01	Ward et al.	Applicant
US4953565(A)	1990-09-01	Tachibana et al.	Applicant
US4969880(A)	1990-11-01	Zamierowski	Applicant
US4976726(A)	1990-12-01	Haverstock	Examiner
US4985019(A)	1991-01-01	Michelson	Applicant
US5007921(A)	1991-04-01	Brown	Applicant
US5007936(A)	1991-04-01	Woolson	Applicant
US5019083(A)	1991-05-01	Klapper et al.	Applicant
US5037397(A)	1991-08-01	Kalt et al.	Applicant
US5045054(A)	1991-09-01	Hood et al.	Applicant
US5086170(A)	1992-02-01	Luheshi et al.	Applicant
US5092858(A)	1992-03-01	Benson et al.	Applicant
US5100396(A)	1992-03-01	Zamierowski	Applicant
US5112338(A)	1992-05-01	Anspach, III	Applicant
US5134994(A)	1992-08-01	Say	Applicant
US5149331(A)	1992-09-01	Ferdman et al.	Applicant
US5167613(A)	1992-12-01	Karami et al.	Applicant
US5169399(A)	1992-12-01	Ryland et al.	Applicant
US5176663(A)	1993-01-01	Svedman et al.	Applicant
US5215522(A)	1993-06-01	Page et al.	Applicant
USD337639(S)	1993-07-01	Beckman	Applicant
US5232453(A)	1993-08-01	Plass et al.	Applicant
US5261893(A)	1993-11-01	Zamierowski	Applicant
US5278100(A)	1994-01-01	Doan et al.	Applicant
US5279550(A)	1994-01-01	Habib et al.	Applicant
US5291887(A)	1994-03-01	Stanley et al.	Applicant
US5298015(A)	1994-03-01	Komatsuzaki et al.	Applicant
US5318570(A)	1994-06-01	Hood et al.	Applicant
US5342376(A)	1994-08-01	Ruff	Applicant
US5344415(A)	1994-09-01	DeBusk et al.	Applicant
US5358494(A)	1994-10-01	Svedman	Applicant
US5383897(A)	1995-01-01	Wholey	Applicant
US5423885(A)	1995-06-01	Williams	Applicant
US5437622(A)	1995-08-01	Carion	Applicant
US5437651(A)	1995-08-01	Todd et al.	Applicant
US5507833(A)	1996-04-01	Bohn	Applicant
US5522901(A)	1996-06-01	Thomas et al.	Applicant
US5527293(A)	1996-06-01	Zamierowski	Applicant
USD372309(S)	1996-07-01	Heldreth	Applicant
US5549584(A)	1996-08-01	Gross	Applicant
US5556375(A)	1996-09-01	Ewall	Applicant
US5580353(A)	1996-12-01	Mendes	Applicant
US5584859(A)	1996-12-01	Brotz	Applicant
US5607388(A)	1997-03-01	Ewall	Applicant
US5630819(A)	1997-05-01	Ashby et al.	Applicant
US5636643(A)	1997-06-01	Argenta et al.	Applicant
US5645081(A)	1997-07-01	Argenta et al.	Applicant
US5716360(A)	1998-02-01	Baldwin et al.	Applicant
US5738686(A)	1998-04-01	Budein-Meesenburg	Applicant
US5785700(A)	1998-07-01	Olson	Applicant
US5800546(A)	1998-09-01	Marik et al.	Applicant
US5827246(A)	1998-10-01	Bowen	Applicant
US5846244(A)	1998-12-01	Cripe	Applicant
US5911222(A)	1999-06-01	Lawrence et al.	Applicant
US5921972(A)	1999-07-01	Skow	Applicant
US5931855(A)	1999-08-01	Buncke	Applicant
US5941859(A)	1999-08-01	Lerman	Applicant
US6071267(A)	2000-06-01	Zamierowski	Applicant
US6113618(A)	2000-09-01	Nic	Applicant
US6126659(A)	2000-10-01	Wack	Applicant
US6135116(A)	2000-10-01	Vogel et al.	Applicant
US6142982(A)	2000-11-01	Hunt et al.	Applicant
US6146423(A)	2000-11-01	Cohen et al.	Applicant
US6159246(A)	2000-12-01	Mendes et al.	Applicant
US6174306(B1)	2001-01-01	Fleischmann	Applicant
US6179804(B1)	2001-01-01	Satterfield	Applicant
US6190391(B1)	2001-02-01	Stubbs	Applicant
US6190392(B1)	2001-02-01	Vandewalle	Applicant
US6203563(B1)	2001-03-01	Fernandez	Applicant
US6241747(B1)	2001-06-01	Ruff	Applicant
US6270517(B1)	2001-08-01	Brotz	Examiner
USRE37358(E)	2001-09-01	Del Rio et al.	Applicant
US6287316(B1)	2001-09-01	Agarwal et al.	Applicant
US6293929(B1)	2001-09-01	Smith et al.	Applicant
US6345623(B1)	2002-02-01	Heaton et al.	Applicant
US6355215(B1)	2002-03-01	Poggie et al.	Applicant
US6377653(B1)	2002-04-01	Lee et al.	Applicant
US6398767(B1)	2002-06-01	Fleischmann	Applicant
US6430427(B1)	2002-08-01	Lee et al.	Applicant
US6488643(B1)	2002-12-01	Tumey et al.	Applicant
US6493568(B1)	2002-12-01	Bell et al.	Applicant
US6500209(B1)	2002-12-01	Kolb	Applicant
US6503281(B1)	2003-01-01	Mallory	Applicant
US6553998(B2)	2003-04-01	Heaton et al.	Applicant
US6620132(B1)	2003-09-01	Skow	Applicant
US6626891(B2)	2003-09-01	Ohmstede	Applicant
US6645226(B1)	2003-11-01	Jacobs et al.	Applicant
US6669735(B1)	2003-12-01	Pelissier	Examiner
US6685681(B2)	2004-02-01	Lockwood et al.	Applicant
US6695823(B1)	2004-02-01	Lina et al.	Applicant
US6726706(B2)	2004-04-01	Dominguez	Applicant
US6752794(B2)	2004-06-01	Lockwood et al.	Applicant
US6800074(B2)	2004-10-01	Henley et al.	Applicant
US6814079(B2)	2004-11-01	Heaton et al.	Applicant
US6991643(B2)	2006-01-01	Saadat	Examiner
US2002/0022861(A1)	2002-02-01	Jacobs et al.	Examiner
US2002/0029063(A1)	2002-03-01	Wittmann	Examiner
US2002/0077661(A1)	2002-06-01	Saadat	Applicant
US2002/0099447(A1)	2002-07-01	Mears et al.	Applicant
US2002/0115951(A1)	2002-08-01	Norstrem et al.	Applicant
US2002/0116067(A1)	2002-08-01	Mears et al.	Applicant
US2002/0120185(A1)	2002-08-01	Johnson	Applicant
US2002/0143286(A1)	2002-10-01	Tumey	Applicant
US2002/0183565(A1)	2002-12-01	Leavanoni et al.	Applicant
US2003/0050594(A1)	2003-03-01	Zamierowski	Applicant
US2003/0097135(A1)	2003-05-01	Penenberg	Applicant
US2004/0039415(A1)	2004-02-01	Zamierowski	Applicant
US2005/0043818(A1)	2005-02-01	Bellon Caneiro et al.	Examiner
AU550575(A1)	1982-08-01		Applicant
AU745271	1999-04-01		Applicant
AU755496	2002-02-01		Applicant
CA2005436	1990-06-01		Applicant
DE2640413(A1)	1978-03-01		Applicant
DE4306478(A1)	1994-09-01		Applicant
DE29504378(U1)	1995-10-01		Applicant
EP100148(A1)	1984-02-01		Applicant
EP117632(A2)	1984-09-01		Applicant
EP161865(A2)	1985-11-01		Applicant
EP358302(A2)	1990-03-01		Applicant
EP1018967(B1)	2004-08-01		Applicant
GB692578	1953-06-01		Applicant
GB2197789(A)	1988-06-01		Applicant
GB2220357(A)	1990-01-01		Applicant
GB2235877(A)	1991-03-01		Applicant
GB2333965(A)	1999-08-01		Applicant
GB2329127(B)	2000-08-01		Applicant
JP4129536	1992-04-01		Applicant
SG71559	2002-04-01		Applicant
WO80/02182	1980-10-01		Applicant
WO93/09727	1993-05-01		Applicant
WO94/20041	1994-09-01		Applicant
WO96/05873	1996-02-01		Applicant
WO97/18007	1997-05-01		Applicant
WO99/13793	1999-03-01		Applicant

Non-Patent Literature (20)

Mendez-Eastman, Susan, RN; “When Wounds Won't Heal”; Jan. 1998, vol. 61 (1); Medical Economics Company, Inc., Montvale, NJ; pp. 20-24.Examiner
Miyauchi, Takayuki, et al.; “Repair of Incisional Hernia with Prolene Hernia System”; J. Med. Invest. 50:108-111, 2003; Received for publication Aug. 8, 2002.Examiner
Louis C. Argenta, MD and Michael J. Morykwas, PhD; “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Clinical Experience”; Annals of Plastic Surgery, vol. 38, No. 6, Jun. 1997; pp. 563-576.Applicant
Susan Mendez-Eastman, RN; “When Wounds Won't Heal” RN Jan. 1998, vol. 61 (1); Medical Economics Company, Inc., Montvale, NJ, USA; pp. 20-24.Applicant
James H. Blackburn, II, MD, et al; “Negative-Pressure Dressings as a Bolster for Skin Grafts”; Annals of Plastic Surgery, vol. 40, No. 5, May 1998, pp. 453-457.Applicant
John Masters; “Reliable, Inexpensive and Simple Suction Dressings”; Letter to the Editor, British Journal of Plastic Surgery, 1998, vol. 51 (3), p. 267; Elsevier Science/The British Association of Plastic Surgeons, UK.Applicant
S.E. Greer, et al “The Use of Subatmospheric Pressure Dressing Therapy to Close Lymphocutaneous Fistulas of the Groin” British Journal of Plastic Surgery (2000), 53, pp. 484-487.Applicant
George V. Letsou, MD., et al; “ Stimulation of Adenylate Cyclase Activity in Cultured Endothelial Cells Subjected to Cyclic Stretch”; Journal of Cardiovascular Surgery, 31, 1990, pp. 634-639.Applicant
Orringer, Jay, et al; “Management of Wounds in Patients with Complex Entercutaneous Fistulas”; Surgery, Gynecology & Obstetrics, Jul. 1987, vol. 165, pp. 79-80.Applicant
International Search Report for PCT International Application PCT/GB95/01983; Nov. 23, 1995.Applicant
PCT International Search Report for PCT International Application PCT/GB98/02713; Jan. 8, 1999.Applicant
PCT Written Opinion; PCT International Application PCT/GB98/02713; Jun. 8, 1999.Applicant
PCT International Examination and Search Report, PCT International Application PCT/GB96/02802; Jan. 15, 1998 & Apr. 29, 1997.Applicant
PCT Written Opinion, PCT International Application PCT/GB96/02802; Sep. 3, 1997.Applicant
Dattilo, Philip P., Jr., et al; “Medical Textiles: Application of an Absorbable Barbed Bi-directional Surgical Suture”; Journal of Textile and Apparel, Technology and Management. vol. 2, Issue 2, Spring 2002, pp. 1-5.Applicant
Kostyuchenok, B.M., et al; “Vacuum Treatment in the Surgical Management of Purulent Wounds”; Vestnik Khirurgi, Sep. 1986, pp. 18-21 and 6 page English translation thereof.Applicant
Davydov, Yu. A., et al; “Vacuum Therapy in the Treatment of Purulent Lactation Mastitis”; Vestnik Khirurgi, May 14, 1986, pp. 66-70, and 9 page English translation thereof.Applicant
Yusupov. Yu. N., et al; “Active Wound Drainage”, Vestnik Khirurgi, vol. 138, Issue 4, 1987, and 7 page English translation thereof.Applicant
Davydov, Yu. A., et al; “Bacteriological and Cytological Assessment of Vacuum Therapy for Purulent Wounds”; Vestnik Khirurgi, May 2, 1986, pp. 42-46, and 7 page English translation thereof.Applicant
Davydov, Yu. A., et al; “Concepts for the Clinical-Biological Management of the Wound Process in the Treatment of Purulent Wounds by Means of Vacuum Therapy”; Vestnik Khirurgi, Jul. 7, 1980, pp. 132-136, and 8 page English translation thereof.Applicant

Abstract